Immunity Pharma Shows New Data IPL344 Efficacy in ALS
07 Apr 2025 //
PR NEWSWIRE
Immunity Pharma Presents New Data Efficacy of IPL344 in ALS
07 Apr 2025 //
PR NEWSWIRE
Immunity Announces Positive Top Line Results from Phase 2a Trial with IPL344
17 Jan 2024 //
PR NEWSWIRE